• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

胆道癌的研究进展

Research Progress of Biliary Tract Cancers.

作者信息

Fonkoua Lionel Aurelien A Kankeu, Mahipal Amit

机构信息

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Cancers (Basel). 2021 Feb 22;13(4):919. doi: 10.3390/cancers13040919.

DOI:10.3390/cancers13040919
PMID:33671644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7926639/
Abstract

This series of nine articles (three original articles, six reviews) is presented by international leaders in biliary tract cancers (BTC) [...].

摘要

这一系列九篇文章（三篇原创文章、六篇综述）由胆道癌（BTC）领域的国际领军人物撰写[……]

相似文献

1
Research Progress of Biliary Tract Cancers.胆道癌的研究进展
Cancers (Basel). 2021 Feb 22;13(4):919. doi: 10.3390/cancers13040919.
2
Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.胆道癌的家族风险：一项基于犹他州人群的研究。
Dig Dis Sci. 2016 Dec;61(12):3627-3632. doi: 10.1007/s10620-016-4310-3. Epub 2016 Sep 21.
3
[Advance in immunotherapy on biliary tract cancers].[胆道癌免疫治疗的进展]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):156-160. doi: 10.3760/cma.j.cn112139-20200515-00382.
4
Immunotherapy of biliary tract cancer.胆管癌的免疫治疗
Tumour Biol. 2016 Mar;37(3):2817-21. doi: 10.1007/s13277-015-4743-x. Epub 2016 Jan 4.
5
Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.胆道癌：流行病学、分子发病机制及遗传风险关联
Chin Clin Oncol. 2016 Oct;5(5):61. doi: 10.21037/cco.2016.10.09.
6
FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.法尼醇X受体激动剂通过小异二聚体蛋白依赖性抑制Bcl-xL表达增强胆管癌细胞对顺铂的敏感性。
Oncotarget. 2016 Jun 7;7(23):34617-29. doi: 10.18632/oncotarget.8964.
7
Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.紫藤凝集素唾液酸化粘蛋白核心多肽1是胆管癌和肝内胆管癌的敏感生物标志物：一项多中心研究。
J Gastroenterol. 2017 Feb;52(2):218-228. doi: 10.1007/s00535-016-1230-0. Epub 2016 Jun 29.
8
Clinical and Translational Research Challenges in Biliary Tract Cancers.胆道肿瘤临床与转化研究的挑战
Curr Med Chem. 2020;27(29):4756-4777. doi: 10.2174/0929867327666200123090153.
9
Surgical management of biliary tract cancers.胆道癌的外科治疗
Chin Clin Oncol. 2016 Oct;5(5):63. doi: 10.21037/cco.2016.10.03.
10
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).一项多机构试验（东京胆道癌研究组：TOSBIC01）中辅助替吉奥治疗可切除胆道癌一年的前瞻性可行性研究。
BMC Cancer. 2020 Jul 23;20(1):688. doi: 10.1186/s12885-020-07185-6.

本文引用的文献

1
Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation.部分无法切除的肝门部胆管癌（pCCA）患者可从肝移植中获得长期益处。
Cancers (Basel). 2020 Oct 27;12(11):3157. doi: 10.3390/cancers12113157.
2
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study.CAP7.1作为晚期胆管癌二线治疗的疗效与安全性：一项随机II期研究的数据
Cancers (Basel). 2020 Oct 27;12(11):3149. doi: 10.3390/cancers12113149.
3
Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review.用于胆管癌诊疗的生物标志物翻译：一项系统综述
Cancers (Basel). 2020 Sep 30;12(10):2817. doi: 10.3390/cancers12102817.
4
Prevention and treatment of FGFR inhibitor-associated toxicities.成纤维细胞生长因子受体抑制剂相关毒性的预防和治疗。
Crit Rev Oncol Hematol. 2020 Nov;155:103091. doi: 10.1016/j.critrevonc.2020.103091. Epub 2020 Sep 1.
5
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma.晚期/转移性胆管癌全身治疗的最新进展
Cancers (Basel). 2020 Sep 11;12(9):2599. doi: 10.3390/cancers12092599.
6
Role of Chemokines in the Biology of Cholangiocarcinoma.趋化因子在胆管癌生物学中的作用
Cancers (Basel). 2020 Aug 7;12(8):2215. doi: 10.3390/cancers12082215.
7
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine.胆管癌的分子与免疫特征：向个性化医疗的范式转变
Cancers (Basel). 2020 Aug 6;12(8):2190. doi: 10.3390/cancers12082190.
8
Examination of Prognostic Factors Affecting Long-Term Survival of Patients with Stage 3/4 Gallbladder Cancer without Distant Metastasis.影响无远处转移的3/4期胆囊癌患者长期生存的预后因素分析
Cancers (Basel). 2020 Jul 27;12(8):2073. doi: 10.3390/cancers12082073.
9
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm.晚期胆管癌的靶向治疗：一种不断发展的模式
Cancers (Basel). 2020 Jul 24;12(8):2039. doi: 10.3390/cancers12082039.
10
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.奥沙利铂、吉西他滨和卡培他滨或顺铂与吉西他滨治疗晚期胆管癌患者的随机II期试验
Cancers (Basel). 2020 Jul 20;12(7):1975. doi: 10.3390/cancers12071975.